4//SEC Filing
Sebelius Kathleen 4
Accession 0001818382-24-000143
CIK 0001818382other
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 4:15 PM ET
Size
8.8 KB
Accession
0001818382-24-000143
Insider Transaction Report
Form 4
Humacyte, Inc.HUMA
Sebelius Kathleen
Director
Transactions
- Exercise/Conversion
Stock Options (right to buy)
2024-06-14−39,389→ 0 totalExercise: $2.56From: 2018-09-01Exp: 2025-09-01→ Common Stock (39,389 underlying) - Award
Stock Options (right to buy)
2024-06-13+50,000→ 50,000 totalExercise: $7.20Exp: 2034-06-13→ Common Stock (50,000 underlying) - Exercise/Conversion
Common Stock
2024-06-14$2.56/sh+39,389$100,836→ 39,389 total
Footnotes (1)
- [F1]The first 25% of the option becomes exercisable on June 13, 2025, after which 1/48 of the option will become exercisable on the 13th of each month through June 13, 2028.
Documents
Issuer
Humacyte, Inc.
CIK 0001818382
Entity typeother
Related Parties
1- filerCIK 0001654316
Filing Metadata
- Form type
- 4
- Filed
- Jun 16, 8:00 PM ET
- Accepted
- Jun 17, 4:15 PM ET
- Size
- 8.8 KB